← Back to companies
Amgen
AMGNHealthcareNMS$190.8B
AMGN SEC filings last scanned 4 Oct 2026, 18:58 UTC
CEO Timeline
Robert A. BradwayCurrent
May 2012 — Present(14y 5mo)
Robert A. Bradway was appointed Chief Executive Officer of Amgen Inc., effective May 23, 2012, succeeding Kevin W. Sharer.
2 source filings — click to expand
Kevin W. Sharer
Since at least Mar 2005 — May 2012(7y 2mo)
planned retirement
2 source filings — click to expand